Study: Benvenue’s Kiva system outperforms Balloon Kyphoplasty

KAST Pivotal Trial Results Published in Spine Demonstrate Benvenue Medical's Kiva® VCF Treatment System Meets or Exceeds Balloon Kyphoplasty Performance (press release)

SANTA CLARA, Calif.--(BUSINESS WIRE)--Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced that results from the KAST pivotal trial have been published online in the journal Spine. KAST showed that the Kiva® VCF Treatment System, a novel implant for vertebral augmentation, successfully met the primary endpoint of non-inferiority to balloon kyphoplasty (BKP) in the treatment of o...